Skip to content

Xencor XNCR Total Liabilities

Total Liabilities at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$9.45B+15.8%
Janux Therapeutics logo
Janux TherapeuticsJANX
$86.69M+126%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$369.03M+14.9%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$48.99M+24.6%
Absci Corporation logo
Absci CorporationABSI
$23.62M-29.8%
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's total liabilities?
Xencor (XNCR) reported total liabilities of $221.21M in Q1 2026.
How has Xencor's total liabilities changed year-over-year?
Xencor's total liabilities decreased by 16.5% year-over-year, from $264.82M to $221.21M.
What is the long-term trend for Xencor's total liabilities?
Over 5 years (2020 to 2025), Xencor's total liabilities has grown at a 12.9% compound annual growth rate (CAGR), from $130.8M to $239.91M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.